Tatva Chintan Pharma Chem Q2FY22 consolidated PAT surges to Rs. 32.41 Cr

For the 6 months period ended September 30, 2021, the company's total income is Rs 235.01 crore, against Rs 114.26 crore in the previous year (YoY).

Tatva Chintan Pharma Chem registered a total income of Rs 126.41 crore for the quarter ended September 30, 2021, against Rs 61.99 crore in the corresponding quarter of the previous year (YoY) and Rs 108.59 crore in previous quarter (QoQ).

For the quarter ended September 30, 2021(Q2 FY2022), the company's net profit is Rs 32.41 crore, against Rs 3.55 crore in the corresponding quarter of the previous year (YoY) and Rs 23.14 crore in previous quarter (QoQ).

For the 6 months period ended September 30, 2021, the company's total income is Rs 235.01 crore, against Rs 114.26 crore in the previous year (YoY).

The net profit is at Rs 55.55 crore for the 6 months period ended September 30, 2021compared to rs 10.26 crore in the previous year (YoY).